Déglon N - Search Results

1

A gene therapy approach for the treatment of amyotrophic lateral sclerosis and Parkinson's disease.

Zurn AD, Tseng JL, Déglon N, Joseph JM, Aebischer P. Zurn AD, et al. Among authors: deglon n. Adv Pharmacol. 1998;42:929-31. doi: 10.1016/s1054-3589(08)60899-6. Adv Pharmacol. 1998. PMID: 9328050 No abstract available.

2

Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients.

Aebischer P, Schluep M, Déglon N, Joseph JM, Hirt L, Heyd B, Goddard M, Hammang JP, Zurn AD, Kato AC, Regli F, Baetge EE. Aebischer P, et al. Among authors: deglon n. Nat Med. 1996 Jun;2(6):696-9. doi: 10.1038/nm0696-696. Nat Med. 1996. PMID: 8640564 Clinical Trial.

3

Gene therapy for amyotrophic lateral sclerosis (ALS) using a polymer encapsulated xenogenic cell line engineered to secrete hCNTF.

Aebischer P, Pochon NA, Heyd B, Deglon N, Joseph JM, Zurn AD, Baetge EE, Hammang JP, Goddard M, Lysaght M, Kaplan F, Kato AC, Schluep M, Hirt L, Regli F, Porchet F, De Tribolet N. Aebischer P, et al. Among authors: deglon n. Hum Gene Ther. 1996 May 1;7(7):851-60. doi: 10.1089/hum.1996.7.7-851. Hum Gene Ther. 1996. PMID: 8860837

4

Rescue of motoneurons from axotomy-induced cell death by polymer encapsulated cells genetically engineered to release CNTF.

Tan SA, Déglon N, Zurn AD, Baetge EE, Bamber B, Kato AC, Aebischer P. Tan SA, et al. Among authors: deglon n. Cell Transplant. 1996 Sep-Oct;5(5):577-87. doi: 10.1177/096368979600500507. Cell Transplant. 1996. PMID: 8889216

5

Central nervous system delivery of recombinant ciliary neurotrophic factor by polymer encapsulated differentiated C2C12 myoblasts.

Déglon N, Heyd B, Tan SA, Joseph JM, Zurn AD, Aebischer P. Déglon N, et al. Hum Gene Ther. 1996 Nov 10;7(17):2135-46. doi: 10.1089/hum.1996.7.17-2135. Hum Gene Ther. 1996. PMID: 8934227

6

A gene therapy approach to regulated delivery of erythropoietin as a function of oxygen tension.

Rinsch C, Régulier E, Déglon N, Dalle B, Beuzard Y, Aebischer P. Rinsch C, et al. Among authors: deglon n. Hum Gene Ther. 1997 Nov 1;8(16):1881-9. doi: 10.1089/hum.1997.8.16-1881. Hum Gene Ther. 1997. PMID: 9382954

7

Continuous delivery of human and mouse erythropoietin in mice by genetically engineered polymer encapsulated myoblasts.

Régulier E, Schneider BL, Déglon N, Beuzard Y, Aebischer P. Régulier E, et al. Among authors: deglon n. Gene Ther. 1998 Aug;5(8):1014-22. doi: 10.1038/sj.gt.3300687. Gene Ther. 1998. PMID: 10326023

8

Cellular xenotransplantation.

Aebischer P, Hottinger AF, Déglon N. Aebischer P, et al. Among authors: deglon n. Nat Med. 1999 Aug;5(8):852. doi: 10.1038/11271. Nat Med. 1999. PMID: 10426290 No abstract available.

9

Improvement of mouse beta-thalassemia upon erythropoietin delivery by encapsulated myoblasts.

Dalle B, Payen E, Regulier E, Deglon N, Rouyer-Fessard P, Beuzard Y, Aebischer P. Dalle B, et al. Among authors: deglon n. Gene Ther. 1999 Feb;6(2):157-61. doi: 10.1038/sj.gt.3300812. Gene Ther. 1999. PMID: 10435099

10

Lentiviral gene transfer to the nonhuman primate brain.

Kordower JH, Bloch J, Ma SY, Chu Y, Palfi S, Roitberg BZ, Emborg M, Hantraye P, Déglon N, Aebischer P. Kordower JH, et al. Among authors: deglon n. Exp Neurol. 1999 Nov;160(1):1-16. doi: 10.1006/exnr.1999.7178. Exp Neurol. 1999. PMID: 10630186

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters